Aini is currently working on cross-disciplinary projects that will extract and deploy truly innovative, but mature models from across industry sectors to address some of the health challenges specifically in resource deprived settings. The projected 388 million people dying of non-communicable diseases by 2015, and with the majority speculated to occur in the most productive age groups and 80% of the deaths taking place in low and middle income countries (LMICs), the limited capacity of LMICs to respond adequately adds to this colossal challenge. However, in the presence of timely and innovative interventions, better health levels will improve human capital and free much needed resources for continued economic growth, and as such, reduce proliferation down the spiral of ill health and poverty.
Under this umbrella, Aini is highly invested in improving cancer survivorship; the social-economic as well as psychosocial well-being entities which engulf cancer survivors and their immediate families in Malaysia. She works closely with multiple NGOs to contribute to policy briefs. She advocates early education on cancer and screening as one of the fundamental tools for LMICs to address the health and economic challenges brought about by this disease.
As a molecular and structural biologist, Aini investigated proteins implicated in arrhythmia and heart failure during her appointment at the University of Manchester's Medical School. Previous to that, she worked on proteins associated with neurodegenerative diseases while based at the MRC-Laboratory of Molecular Biology in Cambridge.
In addition to her current work on innovation in healthcare and cancer survivorship, she is keen on exploring local and underutilized plants for disease prevention and management. Scientific based investigations have just started to corroborate many of these otherwise anecdotal claims.